Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 16, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2020. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 19.1B USD
- Positions
- 831
- Share of the ten largest
- 14.6%
The ten largest positions Q4 2020
- Alphabet Inc. (Class A) 3.3%▲ +74.6%
- Advanced Micro Devices 1.8%▲ +184.2%
- Meta Platforms 1.6%▲ +34.9%
- Visa Inc. 1.5%▲ +240.1%
- Microsoft 1.2%▲ +4.9%
- AstraZeneca 1.1%▲ +774.8%
- Uber 1.1%new
- Dell Technologies 1.1%▲ +8.6%
- Micron Technology 1.0%▲ +98.9%
- JD.com (ADR) 1.0%▲ +23.3%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q4 2020
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Bunge Limited | < 0.1% | 208,536 | 13.7M USD | −2.1% reduced | Q2 2014 or earlier 27 quarters |
| Cimarex Energy Co | 0.1% | 646,354 | 24.2M USD | −60.1% reduced | Q1 2016 20 quarters |
| Popular Inc | 0.1% | 483,243 | 27.2M USD | −40.5% reduced | Q4 2016 17 quarters |
| AMZN Amazon | 0.8% | 46,753 | 152.3M USD | −70.3% reduced | Q1 2017 16 quarters |
| HCA HCA Healthcare | 0.2% | 212,067 | 34.9M USD | −70.1% reduced | Q4 2017 13 quarters |
| MDT Medtronic | < 0.1% | 10,474 | 1.2M USD | −98.0% reduced | Q4 2017 13 quarters |
| Voya Financial Inc | < 0.1% | 8,000 | 470.0K USD | −98.8% reduced | Q4 2017 13 quarters |
| MS Morgan Stanley | < 0.1% | 160,000 | 11.0M USD | −54.4% reduced | Q1 2018 12 quarters |
| Gds HLDGS Ltd | < 0.1% | 4,400 | 412.0K USD | −86.1% reduced | Q1 2018 12 quarters |
| Sailpoint Technologies HLDGS | 0.1% | 375,908 | 20.0M USD | −40.3% reduced | Q2 2018 11 quarters |
| Advance Auto Parts Inc | < 0.1% | 95,776 | 15.1M USD | −72.8% reduced | Q2 2018 11 quarters |
| Navient Corporation | < 0.1% | 106,000 | 1.0M USD | −88.4% reduced | Q2 2018 11 quarters |
| NXPI NXP Semiconductors | 0.6% | 682,350 | 108.5M USD | −24.7% reduced | Q3 2018 10 quarters |
| Repligen Corp | 0.4% | 381,405 | 73.1M USD | −42.8% reduced | Q3 2018 10 quarters |
| Ptc Therapeutics Inc | 0.3% | 947,000 | 57.8M USD | −13.6% reduced | Q3 2018 10 quarters |
| DOV Dover Corporation | 0.1% | 175,000 | 22.1M USD | −30.0% reduced | Q3 2018 10 quarters |
| GPN Global Payments | < 0.1% | 57,715 | 12.4M USD | −78.8% reduced | Q3 2018 10 quarters |
| Insmed Inc | < 0.1% | 280,101 | 9.3M USD | −8.0% reduced | Q3 2018 10 quarters |
| SYF Synchrony Financial | < 0.1% | 75,000 | 2.6M USD | −96.7% reduced | Q3 2018 10 quarters |
| MDLZ Mondelez International | 0.2% | 713,612 | 41.7M USD | −48.7% reduced | Q4 2018 9 quarters |
| Vonage HLDGS Corp | 0.2% | 2,561,306 | 33.0M USD | −30.7% reduced | Q4 2018 9 quarters |
| Gentex Corp | 0.2% | 953,660 | 32.4M USD | −42.3% reduced | Q4 2018 9 quarters |
| AON Aon plc | < 0.1% | 48,163 | 10.2M USD | −73.5% reduced | Q4 2018 9 quarters |
| Radian Group Inc | < 0.1% | 467,900 | 9.5M USD | −74.8% reduced | Q4 2018 9 quarters |
| Conmed Corp | < 0.1% | 58,556 | 6.6M USD | −93.1% reduced | Q4 2018 9 quarters |
| Zuora Inc | < 0.1% | 452,651 | 6.3M USD | −68.1% reduced | Q4 2018 9 quarters |
| Enerplus Corp | < 0.1% | 1,150,000 | 3.6M USD | −76.1% reduced | Q4 2018 9 quarters |
| American Finl Group Inc Ohio | < 0.1% | 7,900 | 692.0K USD | −86.7% reduced | Q4 2018 9 quarters |
| ON ON Semiconductor | 0.2% | 1,070,233 | 35.0M USD | −48.2% reduced | Q1 2019 8 quarters |
| Fidelity National Financial | 0.2% | 763,579 | 29.8M USD | −70.8% reduced | Q1 2019 8 quarters |
| Aurinia Pharmaceuticals Inc | 0.2% | 2,139,461 | 29.6M USD | −8.7% reduced | Q1 2019 8 quarters |
| FICO Fair Isaac | < 0.1% | 30,120 | 15.4M USD | −37.0% reduced | Q1 2019 8 quarters |
| Childrens Pl Inc | < 0.1% | 293,845 | 14.7M USD | −37.8% reduced | Q1 2019 8 quarters |
| Select Sector SPDR TR | < 0.1% | 305,750 | 11.6M USD | −50.7% reduced | Q1 2019 8 quarters |
| Copa Holdings SA | < 0.1% | 126,070 | 9.7M USD | −68.8% reduced | Q1 2019 8 quarters |
| Methanex Corp | < 0.1% | 186,887 | 8.6M USD | −37.6% reduced | Q1 2019 8 quarters |
| Alleghany Corp Del | < 0.1% | 4,800 | 2.9M USD | −21.3% reduced | Q1 2019 8 quarters |
| Criteo S A | < 0.1% | 134,900 | 2.8M USD | −14.1% reduced | Q1 2019 8 quarters |
| Acorda Therapeutics Inc | < 0.1% | 903,364 | 623.0K USD | −54.8% reduced | Q1 2019 8 quarters |
| ACGL Arch Capital Group | 0.7% | 3,944,982 | 142.3M USD | −19.0% reduced | Q2 2019 7 quarters |
| ROST Ross Stores | 0.3% | 486,110 | 59.7M USD | −49.6% reduced | Q2 2019 7 quarters |
| Renaissancere HLDGS Ltd | 0.2% | 239,754 | 39.8M USD | −72.1% reduced | Q2 2019 7 quarters |
| DG Dollar General | 0.2% | 152,129 | 32.0M USD | −26.8% reduced | Q2 2019 7 quarters |
| Alexion Pharmaceuticals Inc | 0.2% | 200,000 | 31.2M USD | −85.4% reduced | Q2 2019 7 quarters |
| DD DuPont | 0.2% | 413,082 | 29.4M USD | −0.8% reduced | Q2 2019 7 quarters |
| PYPL PayPal | 0.1% | 114,968 | 26.9M USD | −89.3% reduced | Q2 2019 7 quarters |
| Cytokinetics Inc | 0.1% | 1,166,294 | 24.2M USD | −27.4% reduced | Q2 2019 7 quarters |
| Vale S A | < 0.1% | 976,600 | 16.4M USD | −37.8% reduced | Q2 2019 7 quarters |
| Ideaya Biosciences Inc | < 0.1% | 1,111,111 | 15.6M USD | −3.9% reduced | Q2 2019 7 quarters |
| West Pharmaceutical Svsc Inc | < 0.1% | 38,118 | 10.8M USD | −38.2% reduced | Q2 2019 7 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 272 positions.
Plus 47 option positions, value of the underlying shares as reported 1.4B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 559.0M USD
- SPDR Ser TR Put 197.1M USD
- Bristol Myers Squibb Call 124.1M USD
- Alibaba Group (ADR) Call 45.8M USD
- Meta Platforms Call 44.4M USD
- Moderna Put 36.6M USD
- Select Sector SPDR TR Call 35.9M USD
- Ishares TR Put 34.6M USD
- Rh Put 24.2M USD
- Ishares TR Put 22.4M USD
Breakdown by sector
- Technology 11.0%
- Financials 7.6%
- Communication Services 7.2%
- Health Care 6.8%
- Consumer Discretionary 6.3%
- Industrials 4.8%
- Utilities 2.5%
- Consumer Staples 2.3%
- Energy 1.5%
- Materials 0.4%
- Real Estate 0.3%
- not in our coverage 49.2%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors